Tranexamic acid for treatment of bleeding in hemophagocytic lymphohistiocytosis

Thromb Res. 2015 May;135(5):1037-9. doi: 10.1016/j.thromres.2015.02.027. Epub 2015 Feb 27.

Authors

Sigrun Friesecke¹, Stephanie-S Stecher¹, Andreas Greinacher²

Affiliations

¹ Klinik für Innere Medizin B, Kardiologie und Intensivmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.
² Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany. Electronic address: [email protected].

PMID: 25747537
DOI: 10.1016/j.thromres.2015.02.027

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antifibrinolytic Agents / therapeutic use*
Female
Fibrinogen / metabolism
Hemorrhage / blood
Hemorrhage / drug therapy*
Hemorrhage / etiology*
Humans
Lymphohistiocytosis, Hemophagocytic / blood
Lymphohistiocytosis, Hemophagocytic / complications*
Lymphohistiocytosis, Hemophagocytic / drug therapy*
Male
Middle Aged
Tranexamic Acid / therapeutic use*

Substances

Antifibrinolytic Agents
Tranexamic Acid
Fibrinogen